Prognostic Values of Baseline 18F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma
Table 2
Comparison between low and high TMTV and TLG groups.
TMTV
TLG
High ()
Low ()
High ()
Low ()
Sex
Female
11
5
0.086
11
5
0.126
Male
15
20
16
19
Age
>60
10
8
0.629
11
7
0.388
≤60
16
17
16
17
B symptoms
Yes
17
11
0.125
17
11
0.220
No
9
14
10
13
Ann Arbor stage
I-II
0
10
<0.001
2
8
0.020
III/IV
26
15
25
16
ECOG
>1
6
1
0.048
6
1
0.061
≤1
20
24
21
23
BM
Yes
4
3
0.725
4
3
0.811
No
22
22
23
21
LDH
Increased
15
9
0.121
15
9
0.197
—
11
16
12
15
NCCN-IPI
0-3
16
20
0.148
16
20
0.060
4-8
10
5
11
4
No. of extranodal sites
≥2
15
7
0.032
16
6
0.023
<2
11
18
11
18
IPI
≥3
16
6
0.007
17
5
0.002
<3
10
19
10
19
PIT
>1
10
4
0.072
10
4
0.104
≤1
16
21
17
20
SUVmax
>9.545
12
6
0.098
16
2
<0001
≤9.545
14
19
11
22
Note: Statistically significant. Abbreviations: ECOG: Eastern Cooperative Oncology Group; BM: bone marrow; IPI: International Prognostic Index; NCCN-IPI: National Comprehensive Cancer Network International Prognostic Index; PIT: prognostic index for T-cell lymphoma.
